IBUPROFEN- ibuprofen capsule, liquid filled 
Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)

----------

DRUG FACTS

Active ingredient (in each capsule)

Solubilized ibuprofen equal to 200 mg ibuprofen (NSAID)*

(present as the free acid and potassium salt)
*nonsteroidal anti-inflammatory drug

Purpose

Pain reliever/ fever reducer

Uses

Warnings

Allergy alert: Ibuprofen may cause a severe allergic reaction, especially in people allergic to aspirin. Symptoms may include:

If an allergic reaction occurs, stop use and seek medical help right away

Stomach bleeding warning: This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you:

Do not use

  • if you have ever had an allergic reaction to any other pain reliever/fever reducer
  • right before or after heart surgery

Ask a doctor before use if

  • stomach bleeding warning applies to you
  • you have problems or serious side effects from taking pain relievers or fever reducers
  • you have a history of stomach problems, such as heartburn
  • you have high blood pressure, heart disease, liver cirrhosis, kidney disease or asthma 
  • you are taking a diuretic

Ask a doctor or pharmacist before use if you are

  • under a doctor's care for any serious condition
  • taking aspirin for heart attack or stroke, because ibuprofen may decrease this benefit of aspirin
  • taking any other drug

When using this product

  • take with food or milk if stomach upset occurs
  • the risk of heart attack or stroke may increase if you use more than directed or for longer than directed

Stop use and ask a doctor if

  • you experience any of the following signs of stomach bleeding:
    • feel faint
    • have bloody or black stools
    • vomit blood
    • have stomach pain that does not get better
    • pain gets worse or lasts more than 10 days
    • fever gets worse or lasts more than 3 days
    • redness or swelling is present in the painful area
    • any new symptoms appear

If pregnant or breast-feeding,

ask a health professional before use. It is especially important not to use ibuprofen during the last 3 months of pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery

Keep out of reach of children

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

Other information

Inactive ingredients

FD&C blue #1, gelatin, pharmaceutical ink,  polyethylene glycol, potassium hydroxide, purified water, sorbitan, sorbitol.

Questions or comments?

call toll free 1-888-309-9030

Principal Display Panel

Compare to the active ingredient in Advil® Liqui-Gels® †

Ibuprofen Capsules, 200 mg

Pain reliever/ fever reducer (NSAID)

softgels**

(**liquid filled capsules)

†This product is not manufactured or distributed by Pfizer consumer healthcare, owner of the registered trademark Advil® Liqui-Gels®

100 % Quality Guranteed (888)-309-9030

Distributed by DOLGENCORP, LLC

100 MISSION RIDGE, GOODLETTSVILLE, TN 37072

KEEP OUTER CARTON FOR COMPLETE WARNINGS AND PRODUCT INFORMATION.

DO NOT USE IF TAMPER EVIDENT SEAL UNDER CAP IMPRINTED WITH "SEALED FOR YOUR PROTECTION" IS BROKEN OR MISSING

Product Label

DG Health

Ibuprofen capsules 200 mg

IBUPROFEN 
ibuprofen capsule, liquid filled
Product Information
Product TypeHUMAN OTC DRUG LABELItem Code (Source)NDC:55910-199
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
IBUPROFEN (IBUPROFEN) IBUPROFEN200 mg
Inactive Ingredients
Ingredient NameStrength
FD&C BLUE NO. 1 
GELATIN 
POLYETHYLENE GLYCOLS 
POTASSIUM HYDROXIDE 
WATER 
SORBITAN 
SORBITOL 
Product Characteristics
ColorBLUEScoreno score
ShapeCAPSULESize19mm
FlavorImprint Code IB200
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:55910-199-201 in 1 BOX
120 in 1 BOTTLE, PLASTIC
2NDC:55910-199-801 in 1 BOX
280 in 1 BOTTLE, PLASTIC
3NDC:55910-199-121 in 1 BOX
3120 in 1 BOTTLE, PLASTIC
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA07868207/07/2010
Labeler - Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) (068331990)
Registrant - P and L Development of New York Corporation (800014821)

Revised: 9/2012
Document Id: b04d39d0-1b3f-4aec-ae93-068927156476
Set id: 9cf42f9a-ad61-43b2-9f39-dd508ec60d65
Version: 4
Effective Time: 20120925
 
Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)